50. 皮膚筋炎／多発性筋炎 Dermatomyositis Clinical trials / Disease details

臨床試験数 : 182 / 薬物数 : 229 - (DrugBank : 88) / 標的遺伝子数 : 48 - 標的パスウェイ数 : 147

4 trials found

diseases per page:

Showing 1 to 4 of 4 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04613219 (ClinicalTrials.gov)	October 1, 2020	15/9/2020	Correlation Between the Change of Peripheral Lymphocyte Subsets and Clinically Amyopathic Dermatomyo ...	Correlation Between the Change of Peripheral Lymphocyte Subsets and Clinically Amyopathic Dermatomyo ...	Clinically Amyopathic Dermatomyisitis(CAMD)	Drug: Tofacitinib 5 MG [Xeljanz]	Jing Liang	NULL	Recruiting	18 Years	80 Years	All	80		China
2	ChiCTR2000036709	2020-10-01	2020-08-24	Study on early warning of rapid progressive interstitial lung disease in dermatomyositis	Study on early warning of rapid progressive interstitial lung disease in dermatomyositis	Dermatomyositis	Group 1:Glucocorticoid + cyclophosphamide+ cyclosporin;Group 2:Glucocorticoid + cyclophosphamide+ To ...	Zhongshan Hospital of Fudan University	NULL	Pending	18	60	Both	Group 1:15;Group 2:15;	N/A	China
3	ChiCTR1800016629	2017-07-01	2018-06-14	An observation of tofacitinibin patients of MDA5+ clinically amyopathic dermatomyositis with interst ...	An observation of tofacitinibin patients of MDA5+ clinically amyopathic dermatomyositis with interst ...	dermatomyositis	study group:tofacitinib;control group:glucocorticoids+immunosuppressant;	Ren Ji Hospital South Campus, Shanghai Jiaotong University School of Medicine	NULL	Recruiting	18	80	Both	study group:15;control group:35;		China
4	NCT03002649 (ClinicalTrials.gov)	January 2017	20/12/2016	Study of Tofacitinib in Refractory Dermatomyositis	Study of Tofacitinibin Refractory Dermatomyositis (STIR): Proof of Concept, Open-Label Study of 10 P ...	Dermatomyositis	Drug: Tofacitinib	Johns Hopkins University	Pfizer	Completed	18 Years	N/A	All	10	Phase 1	United States

First Previous1Next Last